Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose pharmacokinetic and safety study of human coagulation factor VIII in severe hemophilia A
CTR20263719Phase 4Active
- Sponsor
- Hualan Biological Engineering Inc.
- Start
- Sep 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of antihemophilic factor human in hemophilia A, acquired haemophilia (AH), sponsored by Hualan Biological Engineering Inc.. Started Sep 2026; status: active.
02
Drugs
antihemophilic factor human
03
Conditions
hemophilia Aacquired haemophilia (AH)
Beyond the preview
Go deeper on CTR20263719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263719.